← Eichor
Condition: Hyperphosphatemia Patients On Hemodialysis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hyperphosphatemia Patients On Hemodialysis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
Phase 3 · 1 location(s) · Taisho Pharmaceutical Co., Ltd. · NCT07285291A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Phase 3 · 1 location(s) · Taisho Pharmaceutical Co., Ltd. · NCT07285304A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Phase 3 · 1 location(s) · Taisho Pharmaceutical Co., Ltd. · NCT07548840Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemi
Phase 2 · 2 location(s) · Jemincare · NCT06664125
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.